0002124562-26-000001.txt : 20260326
0002124562-26-000001.hdr.sgml : 20260326
20260326144100
ACCESSION NUMBER: 0002124562-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20260326
DATE AS OF CHANGE: 20260326
EFFECTIVENESS DATE: 20260326
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fund I, a series of Transform Health, LP
CENTRAL INDEX KEY: 0002124562
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-577908
FILM NUMBER: 26797044
BUSINESS ADDRESS:
STREET 1: 17 AVENUE AT PORT IMPERIAL
STREET 2: APT 1102
CITY: WEST NEW YORK
STATE: NJ
ZIP: 07093-7025
BUSINESS PHONE: 2068016359
MAIL ADDRESS:
STREET 1: 17 AVENUE AT PORT IMPERIAL
STREET 2: APT 1102
CITY: WEST NEW YORK
STATE: NJ
ZIP: 07093-7025
D
1
primary_doc.xml
X0708
D
LIVE
0002124562
Fund I, a series of Transform Health, LP
17 AVENUE AT PORT IMPERIAL
APT 1102
WEST NEW YORK
NJ
NEW JERSEY
07093-7025
(360) 340-9337
DELAWARE
None
None
Limited Partnership
true
2026
N/A
Growth Transform Health, LLC
17 Avenue at Port Imperial
apt 1102
West New York
NJ
NEW JERSEY
07093-7025
Director
General Partner of the Issuer
Vasanth
Williams
17 Avenue at Port Imperial
apt 1102
West New York
NJ
NEW JERSEY
07093-7025
Executive Officer
Manager of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
false
2026-03-12
false
true
false
257500
515000
515000
0
false
2
0
0
8000
true
This amount represents estimated administrative and organizational expenses of the fund.
false
Fund I, a series of Transform Health, LP
/s/ Vasanth Williams
Vasanth Williams
Manager of the Issuer
2026-03-26